The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Human papillomavirus (HPV)–related head and neck squamous cell carcinoma (HNSCC) and outcome after treatment with epidermal growth factor receptor inhibitors (EGFR inhib) plus radiotherapy (RT) versus conventional chemotherapy (CT) plus RT.
B. Pajares
No relevant relationships to disclose
J. M. Trigo Perez
No relevant relationships to disclose
M. D. Toledo
No relevant relationships to disclose
M. Alvarez
No relevant relationships to disclose
L. Perez-Villa
No relevant relationships to disclose
C. Gonzalez-Hermoso
No relevant relationships to disclose
A. Rueda
No relevant relationships to disclose
J. A. Medina
No relevant relationships to disclose
B. Jimenez
No relevant relationships to disclose
J. M. Jerez
No relevant relationships to disclose
L. Perez
No relevant relationships to disclose
E. Alba
No relevant relationships to disclose